Cargando…
Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters
Epigallocatechin-3-O-gallate (EGCG) is the major catechin component of green tea (Cameria sinensis), and is known to possess antiviral activities against a wide range of DNA viruses and RNA viruses. However, few studies have examined chemical modifications of EGCG in terms of enhanced antiviral effi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222519/ https://www.ncbi.nlm.nih.gov/pubmed/30262731 http://dx.doi.org/10.3390/molecules23102475 |
_version_ | 1783369224293449728 |
---|---|
author | Kaihatsu, Kunihiro Yamabe, Miyuki Ebara, Yasuhito |
author_facet | Kaihatsu, Kunihiro Yamabe, Miyuki Ebara, Yasuhito |
author_sort | Kaihatsu, Kunihiro |
collection | PubMed |
description | Epigallocatechin-3-O-gallate (EGCG) is the major catechin component of green tea (Cameria sinensis), and is known to possess antiviral activities against a wide range of DNA viruses and RNA viruses. However, few studies have examined chemical modifications of EGCG in terms of enhanced antiviral efficacy. This paper discusses which steps of virus infection EGCG interferes with, citing previous reports. EGCG appears most likely to inhibits the early stage of infections, such as attachment, entry, and membrane fusion, by interfering with viral membrane proteins. According to the relationships between structure and antiviral activity of catechin derivatives, the 3-galloyl and 5′-OH group of catechin derivatives appear critical to antiviral activities. Enhancing the binding affinity of EGCG to virus particles would thus be important to increase virucidal activity. We propose a newly developed EGCG-fatty acid derivative in which the fatty acid on the phenolic hydroxyl group would be expected to increase viral and cellular membrane permeability. EGCG-fatty acid monoesters showed improved antiviral activities against different types of viruses, probably due to their increased affinity for virus and cellular membranes. Our study promotes the application of EGCG-fatty acid derivatives for the prevention and treatment of viral infections. |
format | Online Article Text |
id | pubmed-6222519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62225192018-11-13 Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters Kaihatsu, Kunihiro Yamabe, Miyuki Ebara, Yasuhito Molecules Review Epigallocatechin-3-O-gallate (EGCG) is the major catechin component of green tea (Cameria sinensis), and is known to possess antiviral activities against a wide range of DNA viruses and RNA viruses. However, few studies have examined chemical modifications of EGCG in terms of enhanced antiviral efficacy. This paper discusses which steps of virus infection EGCG interferes with, citing previous reports. EGCG appears most likely to inhibits the early stage of infections, such as attachment, entry, and membrane fusion, by interfering with viral membrane proteins. According to the relationships between structure and antiviral activity of catechin derivatives, the 3-galloyl and 5′-OH group of catechin derivatives appear critical to antiviral activities. Enhancing the binding affinity of EGCG to virus particles would thus be important to increase virucidal activity. We propose a newly developed EGCG-fatty acid derivative in which the fatty acid on the phenolic hydroxyl group would be expected to increase viral and cellular membrane permeability. EGCG-fatty acid monoesters showed improved antiviral activities against different types of viruses, probably due to their increased affinity for virus and cellular membranes. Our study promotes the application of EGCG-fatty acid derivatives for the prevention and treatment of viral infections. MDPI 2018-09-27 /pmc/articles/PMC6222519/ /pubmed/30262731 http://dx.doi.org/10.3390/molecules23102475 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kaihatsu, Kunihiro Yamabe, Miyuki Ebara, Yasuhito Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters |
title | Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters |
title_full | Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters |
title_fullStr | Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters |
title_full_unstemmed | Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters |
title_short | Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters |
title_sort | antiviral mechanism of action of epigallocatechin-3-o-gallate and its fatty acid esters |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222519/ https://www.ncbi.nlm.nih.gov/pubmed/30262731 http://dx.doi.org/10.3390/molecules23102475 |
work_keys_str_mv | AT kaihatsukunihiro antiviralmechanismofactionofepigallocatechin3ogallateanditsfattyacidesters AT yamabemiyuki antiviralmechanismofactionofepigallocatechin3ogallateanditsfattyacidesters AT ebarayasuhito antiviralmechanismofactionofepigallocatechin3ogallateanditsfattyacidesters |